Page last updated: 2024-10-31

neostigmine and Myofascial Pain Syndromes

neostigmine has been researched along with Myofascial Pain Syndromes in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Myofascial Pain Syndromes: Muscular pain in numerous body regions that can be reproduced by pressure on TRIGGER POINTS, localized hardenings in skeletal muscle tissue. Pain is referred to a location distant from the trigger points. A prime example is the TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Monclús, P1
Bosque, M2
Margalef, R2
Colomina, MT1
Valderrama-Canales, FJ1
Just, L1
Santafé, MM2
Sisquella, M1
Romeu, C1
Mayoral, O1
Monterde, S1
Priego, M1
Guerra-Perez, R1
Ortiz, N1
Tomàs, J1

Other Studies

2 other studies available for neostigmine and Myofascial Pain Syndromes

ArticleYear
Shock waves as treatment of mouse myofascial trigger points.
    Pain practice : the official journal of World Institute of Pain, 2023, Volume: 23, Issue:7

    Topics: Animals; Electromyography; Mice; Muscle, Skeletal; Myofascial Pain Syndromes; Neostigmine; Trigger P

2023
Experimental myofascial trigger point creation in rodents.
    Journal of applied physiology (Bethesda, Md. : 1985), 2019, 01-01, Volume: 126, Issue:1

    Topics: Animals; Cholinesterase Inhibitors; Disease Models, Animal; Male; Mice; Myofascial Pain Syndromes; N

2019